This CX Programme is subject to change.

Peripheral Global Stars & Rising Stars and Abstract Presentations - Tuesday, 21st April - Thursday, 23rd April
Venue:   TBA
Peripheral Global Stars and Rising Stars
Chairing:   TBA
Balloon-expandable stent graft for lower limb disease
Speaker:   Ehrin Armstrong, Denver, United States
Retrograde recanalisation of the SFA: From a systematic review to every day practice
Speaker:   Lorenzo Patrone, London, United Kingdom
Experience with vasculomimetic stents
Speaker:   TBA
Role and technique of embolisation in deep venous arterialisation
Speaker:   Jos van den Berg, Lugano, Switzerland
Covered endoprosthesis demonstrates powerful patency in >20cm SFA lesions
Speaker:   TBA
IN.PACT Global Study four-year outcomes
Speaker:   Thomas Zeller, Bad Krozingen, Germany
Advances in treatment for aortoiliac occlusive disease
Speaker:   Frank Arko, Charlotte, United States
Antiplatelet therapy after endovascular intervention: Not as simple as it appears
Speaker:   Chris Twine, Bristol, United Kingdom
Epidural anaesthesia as standalone solution is beneficial for open aortoiliac reconstruction
Speaker:   Joerg Tessarek, Lingen, Germany
Fifteen-year experience of popliteal artery aneurysm treatment with covered endoprosthesis
Speaker:   Nicola Tusini, Reggio Emilia, Italy
Bycross rotational artherectomy with variable tip diameter and active debris aspiration is highly effective for severely calcified and mixed femoropopliteal TASC D lesions: Results from a CE-mark trial
Speaker:   Joerg Tessarek, Lingen, Germany
IN.PACT Global Study 150mm cohort: Outcomes through three years
Speaker:   TBA
Rotational atherectomy system in chronic totally occluded lower limb peripheral arterial disease patients
Speaker:   TBA
Heparin-bonded covered stents vs. bare metal stents for complex femoropopliteal artery lesions and primary patency rates
Speaker:   Csaba Csobay Novák, Budapest, Hungary
Success of requiring proficiency in fempop and iliac artery CTO success in a multi-institutional, multi-specialty vascular institute
Speaker:   Gary Ansel, Columbus, United States
Using a covered endoprosthesis to reline occlusions: Complex cases
Speaker:   Olaf Schouten, Voorburg, Netherlands
Prospective registry for the treatment of iliac occlusion by bare metal stent: Two-year outcomes
Speaker:   TBA
Balloon-expandable endoprosthesis for iliac obstructive disease
Speaker:   Domenico Angiletta, Bari, Italy
The prevalence of critical CAD in patients with documented PAD - the role of CT angiogram and functional assessment
Speaker:   Javier Ruiz Aburto, Ponce, United States
Eight-year results of heparin-bonded PTFE stent grafts
Speaker:   Maria Antonella Ruffino, Turin, Italy
Treatment of TACS C and D lesions in SFA: First insights in the ongoing prospective randomised SPORTS trial
Speaker:   Gunnar Tepe, Rosenheim, Germany
Update on REPLACE study: Heparin-bonded ePTFE graft vs. ePTFE graf
Speaker:   TBA
A novel simplified percutaneous distal axillary artery access technique for complex endovascular interventions
Speaker:   Dominic Howard, Oxford, United Kingdom
Cost efficacy of peripheral arterial disease technologies
Speaker:   Marianne Brodmann, Graz, Austria
How the unique features of a covered endoprosthesis relate to optimal clinical outcomes: A case review
Speaker:   Bertrand Saint-Lebes, Toulouse, France
Complex femoropopliteal interventions require vessel preparation for optimal results
Speaker:   Brian DeRubertis, Los Angeles, United States
Retrograde popliteal approach for endovascular management of chronic total occlusion of superficial femoral artery
Speaker:   Ali Baran Budak, Ankara, Turkey
Outcomes of failed endografts in the superficial femoral artery and the value of collaterals
Speaker:   Michel Reijnen, Arnhem, Netherlands
The shifting demographics of CLI patients and how BEST to choose between open and endovascular therapy
Speaker:   Matthew Menard, Boston, United States
Unexpected late in-stent restenosis after iliofemoral stenting
Speaker:   TBA
Safety and effectiveness of a novel atherectomy system combined used with a drug-eluting balloon in lower extremity arteries
Speaker:   TBA
Flow dynamics in patients with peripheral arterial occlusive disease
Speaker:   Michel Reijnen, Arnhem, Netherlands
Covered endoprosthesis for long lesions: Long-term data
Speaker:   TBA
A systematic review of covered balloon-expandable stents for treating aortoiliac occlusive disease
Speaker:   Patrice Mwipatayi, Perth, Australia
Peripheral Abstract presentations 08:00-10:00
Chairing:   TBA
Effect of different inflation times on the angiographic image after balloon angioplasty in the femoropopliteal segment: A prospective randomised clinical trial (S)
Speaker:   Maxime Elens, Brussels, Belgium
Diagnosis and treatment of silent myocardial ischaemia can reduce postop cardiac complications and improve survival of peripheral vascular surgery patients (S)
Speaker:   Dainis Krievins, Riga, Latvia
Randomised, multicentre trial of a novel drug-coated balloon in the treatment of femoropopliteal artery occlusive disease (S)
Speaker:   Leng Ni, Beijing, China
Hybrid vs. open procedures for iliac-femoral atherosclerotic diseases. Long-term results at 10 years (T)
Speaker:   Marianna Mucignat, Ferrara, Italy
Sulodexide improves capillary blood flow and the quality of life in patients with Raynaud syndrome (T)
Speaker:   Michal Juszynski, Warsaw, Poland
One-year results of the BIOFLEX-COF CRT, comparing high vs. low chronic outward force of nitinol stents in the SFA (T)
Speaker:   Alexander Wressnegger, Vienna, Austria
Primary endpoint presentation of the complete BIO4AMB study: A multicentre, controlled trial evaluating ambulatory endovascular treatment of PAD for 4Fr and 6Fr femoral access strategies (S)
Speaker:   Marianne Brodmann, Graz, Austria
RANGER II SFA: One-year outcomes for diabetic patients treated with a DCB vs. PTA in the SFA (S)
Speaker:   Marianne Brodmann, Graz, Austria
A new VCD specifically designed for small arterial vessel closure of the extremities (S)
Speaker:   Rex Teeslink, Augusta, United States
Focal stenting with a multiple stent delivery system: Final 12-month results of the multicentre LOCOMOTIVE EXTENDED study (S)
Speaker:   Klaus Amendt, Mannheim, Germany
Does tibial angioplasty save limbs in patients with critical limb ischaemia (T)
Speaker:   Terri-Ann Russell, Northampton, United Kingdom
A systematic review of the impact of foot-care education on self-efficacy and self-care in patients with diabetes (T)
Speaker:   Richard Goodall, London, United Kingdom
The effect of direct revascularisation of a target vessel on improving wound healing (T)
Speaker:   Mohamed Rizk, Cairo, Egypt
First-in-man results from a novel device providing real time, quantitative feedback on tissue perfusion during peripheral arterial intervention (S)
Speaker:   Paul Hayes, Cambridge, United Kingdom
The CLEAR survey: An international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention (T)
Speaker:   Graeme Ambler, Bristol, United Kingdom
Geometrical analysis and preliminary results of new generation balloon-expandable stent-grafts vs. self-expanding covered stents for the endovascular reconstruction of the aortic bifurcation (T)
Speaker:   Gianna Saviane, Padova, Italy
A comparison of international guidelines examining recommendations for antithrombotic therapy for atherosclerotic peripheral arterial disease (T)
Speaker:   Jozel Ramirez, Bristol, United Kingdom
Below-the-ankle bypass for extensive lower limb arterial disease (S)
Speaker:   Filippo Benedetto, Messina, Italy
Antiplatelet and anticoagulant use in randomised trials of patients undergoing endovascular intervention for peripheral arterial disease: Systematic review and narrative synthesis (T)
Speaker:   Mahim Qureshi, Bristol, United Kingdom
Target region oxygenation-based endovascular treatment with real-time monitoring of regional tissue oxygen saturation: Initial results using a newly invented tissue oximeter with near-infrared spectroscopy (S)
Speaker:   Naoki Unno, Hamamatsu, Japan
Predicting bleeding complications of endovascular peripheral arterial interventions - a new preprocedural score (T)
Speaker:   Athanasios Tsochatzis, Athens, Greece
Rapid access one-stop CLI pathway: How close are we meeting the VSGBI QiF Standards? (T)
Speaker:   Shanka Benaragama, Colchester, United Kingdom
Two-year outcomes for Eluvia DES in long lesions: IMPERAL long lesion substudy (S)
Speaker:   Frank Vermassen, Ghent, Belgium
Mortality rates in patients treated with paclitaxel drug-coated balloon: A pooled patient level analysis of over 1,000 patients (T)
Speaker:   Brian Forrestal, Washingston, United States
Diabetic limb salvage in octogenarians - is it worth it? (T)
Speaker:   Matthew Tan, London, United Kingdom
Three-month outcomes from the Circulation Foundation and Society of Vascular Nursing joint intermittent claudication study: An interim analysis (T)
Speaker:   Matthew Popplewell, Newport, United Kingdom
Patient-reported outcome measures for patients undergoing major lower limb amputation for peripheral artery disease and/or diabetes: A systematic review and narrative synthesis (T)
Speaker:   Rachael Lucia Morley, Bristol, United Kingdom
SELUTION SLR - the revolution in drug-eluting balloon technology: Impact of calcification on two-year clinical outcome (S)
Speaker:   Thomas Zeller, Bad Krozingen, Germany
A review of hospital episode statistics supports the need of recognised paediatric vascular surgery in England (T)
Speaker:   Jun Cho, London, United Kingdom
Saphenous vein graft bypass versus drug-coated devices in femoropopliteal artery occlusion: A bayesian network meta-analysis (T)
Speaker:   Rui Zhang, Beijing, China
Dual vs. single antiplatelet therapy following peripheral arterial endovascular intervention for chronic limb threatening ischaemia: Retrospective cohort study (S)
Speaker:   Natasha Chinai, Bristol, United Kingdom
Younger patients have worse outcomes ollowing peripheral vascular interventions for suprainguinal arterial occlusive disease
Speaker:   Mohammad Eslami, Pittsburgh, United States
Diabetic patients in a real-world clinical trial treated for peripheral arterial disease with a paclitaxel covered balloon. Twenty four-month results of the BIOLUX P-III All Comers Registry (S)
Speaker:   Patrice Mwipatayi, Perth, Australia
Outcomes of rehabilitation after a major lower limb amputation; a 10-year experience (T)
Speaker:   Arsalan Wafi, London, United Kingdom
Endovascular native vessel recanalization and subsequent graft resection as a treatment option in managing infected prosthetic vascular grafts (S)
Speaker:   Sebastian Carpenter, Hamburg, Germany
Health-related quality of life outcomes and hospitalisation time after autologous micro-fragmented adipose tissue injection in minor amputations for diabetic foot ulceration: results from a randomised-controlled single centre clinical trial (T)
Speaker:   Nicola Leone, Modena, Italy
Fibrin-based delivery of engineered VEGF and PDGF-BB improves angiogenesis and diabetic wound healing (T)
Speaker:   Rosalinda D'Amico, Basel, Switzerland